Yoon Ghil Suk, Wang Wenle, Osunkoya Adeboye O, Lane Zhaoli, Partin Alan W, Epstein Jonathan I
Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA.
J Urol. 2008 Jun;179(6):2203-6; discussion 2206. doi: 10.1016/j.juro.2008.01.114. Epub 2008 Apr 18.
We examined contralateral prostate cancer potentially left behind by focal therapy.
We investigated 100 completely embedded radical prostatectomy specimens in which needle biopsy predicted limited disease (less than 3 positive cores, 50% or less involvement of any positive core, Gleason score 6 or less) and all positive needle cores were unilateral. Clinical stage was T1c in 85 and T2a in 15 cases with the palpable lesion on the positive biopsy side.
There was 1 positive core in 66 cases. On average 13.9% of each positive core was involved with tumor. The mean number of separate tumor nodules per radical prostatectomy was 2.9. In 65 radical prostatectomy specimens there was some tumor contralateral to the positive biopsy side. Total tumor volume in the radical prostatectomy contralateral to the positive biopsy side averaged 0.2 cm(3) (largest 1.3). In 23 cases contralateral tumor volume was greater than biopsy positive side tumor volume. There were 13 cases in which more than 0.5 cm(3) cancer was contralateral to the positive biopsy and 7 with predominantly anterior tumor. Volume contralateral to positive biopsy side could not be predicted by the number of positive cores (1 vs 2) or maximum percent of the core involved. Gleason pattern 4, extraprostatic extension or positive margins were seen contralateral to the positive biopsy side in 13, 1 and 2 cases, respectively.
In a highly selected population with limited unilateral biopsy cancer, tumor contralateral to the positive biopsy side at radical prostatectomy is typically small. However, 20% of radical prostatectomy specimens had some contralateral adverse pathology in terms of size, extraprostatic extension, grade or margins.
我们研究了聚焦治疗后可能遗留的对侧前列腺癌。
我们研究了100例完全包埋的根治性前列腺切除术标本,其中穿刺活检预测疾病局限(阳性芯针少于3个,任何阳性芯针的累及率为50%或更低,Gleason评分6分或更低)且所有阳性穿刺芯针均为单侧。85例临床分期为T1c,15例为T2a,阳性活检侧有可触及病变。
66例有1个阳性芯针。每个阳性芯针平均13.9%有肿瘤累及。每例根治性前列腺切除术标本中独立肿瘤结节的平均数量为2.9个。65例根治性前列腺切除术标本中,阳性活检侧对侧有一些肿瘤。阳性活检侧对侧的根治性前列腺切除术中肿瘤总体积平均为0.2 cm³(最大为1.3 cm³)。23例中,对侧肿瘤体积大于活检阳性侧肿瘤体积。有13例阳性活检对侧有超过0.5 cm³的癌,7例主要为前部肿瘤。阳性活检侧对侧的体积无法通过阳性芯针数量(1个对2个)或芯针累及的最大百分比来预测。分别有13例、1例和2例在阳性活检侧对侧可见Gleason 4级、前列腺外侵犯或切缘阳性。
在高度选择的单侧活检癌局限的人群中,根治性前列腺切除术中阳性活检侧对侧的肿瘤通常较小。然而,20%的根治性前列腺切除术标本在大小、前列腺外侵犯、分级或切缘方面有一些对侧不良病理表现。